G. Imokawa et al., Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes, J INVES DER, 112(1), 1999, pp. 91-96
We recently reported that the epidermis of patients with atopic dermatitis
contains an abnormally expressed sphingomyelin deacylase that yields a larg
e amount of sphingosylphosphorylcholine (SPC) rather than ceramide, In this
study, we characterize inflammatory roles of newly discovered chemicals in
the epidermis by elucidating biologic effects of SPC on intercellular adhe
sion molecules-1 (ICAM-1) expression by human keratinocytes in culture in c
omparison with other sphingolipids. Using fluorescence-activated cell sorte
r analysis, we found that SPC treatment at concentrations of 10-20 mu M sig
nificantly enhanced the expression of ICAM-1 by cultured human keratinocyte
s in a dose-dependent manner after incubation for 15-24 h, and, using north
ern blot analysis, that this was accompanied by increased expression of ICA
M-1 mRNA within 4 h of incubation. Transforming necrosis factor-alpha (TNF-
alpha) levels in the medium of keratinocytes treated at a 10 mu M concentra
tion of SPC were significantly increased by 200%. Furthermore, the SPC-indu
ced ICAM-1 expression was partially abolished by the concomitant addition o
f anti-TNF-alpha, suggesting a partial autocrine involvement of TNF-alpha i
n ICAM-1 expression, Assay of mitogen-activated protein kinase revealed tha
t 10 mu M SPC induced a rapid activation of mitogen-activated protein kinas
e in human keratinocytes, including an increase in its phosphorylation with
in 5 min, which then declined to the baseline control level after 30 min. I
n contrast, sphingomyelin or sphingosine had no significant potential to ac
tivate mitogen-activated protein kinase at the same concentration. These fi
ndings suggest that SPC plays an important role in the inflammatory process
of epidermis in skin diseases, such as atopic dermatitis, with high expres
sion of sphingomyelin deacylase.